Advance Notice: 1 September Announcement - Cal... - CLL Support
Advance Notice: 1 September Announcement - Calquence/Acalabrutinib to go on the Pharmaceutical Benefits Scheme for Australian CLL Patients
You need to be a member of this community to see this post.
Read more about...
15 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Survey for CLL patients having taken Venetoclax or Acalabrutinib
our survey:
Venetoclax (Venclexta) + obinutuzumab (Gazyva) for first-line treatment of CLL/SLL...
UK CLL Forum - updated post lockdown guidance for the management of CLL
the UK CLL Forum issued guidance on managing CLL patients. This guidance has now been updated with...
Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
investigators found that patients who received obinutuzumab plus venetoclax had significantly higher
Early results of the Pirtobrutinib, Obinituzumab, Venetoclax trial I'm on have just been published
COMBINED PIRTOBRUTINIB, VENETOCLAX, AND OBINUTUZUMAB INFIRST-LINE TREATMENT OF PATIENTS WITH...
UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
ALL CLL patients as their first treatment if their doctor feels it is appropriate. This treatment...
Fixed Duration A & O Phase 2 Study...anyone?
Good end to a bad year... My MRD Results are in!
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Vaccines, 3rd dose, LLS results and more
Personalized Treatment Options From 5 Experts for People With CLL 
